SAO PAULO/PARIS (Reuters) -French shipping giant CMA CGM plans to launch a full takeover bid for port terminal operator ...
Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...
Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...
French shipping giant CMA CGM agreed to buy 47.6% of port terminal operator Santos Brasil for 6.3 billion reais ($1.2 billion ...
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...
Veri, which makes a continuous glucose monitor, has announced that it has joined ŌURA, which makes the Oura Ring.
SAO PAULO, Sept 22 (Reuters) - French shipping giant CMA CGM agreed to buy 47.6% of port terminal operator Santos Brasil for 6.3 billion reais ($1.2 billion), and will launch a takeover bid for the ...
CMA CGM Kaohsiung Terminal has ordered five electric hybrid RTG cranes from Konecranes to enhance container handling ...